Research Presentation Sessions: Oncologic Imaging
Gastrointestinal tumours
Lectures
1
Introduction by the moderator - Sofia Gourtsoyianni, Athens / GR
02:00
2
Clinical impact of MRI compared to 68Ga-DOTATATE PET-CT in monitoring metastasised neuroendocrine tumours (NETs): can MRI replace 68Ga-DOTATATE PET-CT? - Charlotte Rijsemus, Amsterdam / NL
08:00
3
Contrast-enhanced computed tomography texture analysis in colon cancer: correlation with genetic markers - Giulio Cabrelle, Padua / IT
08:00
4
Whether quantitative spectral parameters can predict lymph node metastasis in colorectal cancer: a preliminary study - Wenjing Peng, Beijing / CN
08:00
5
A new standard for monitoring treatment response after neoadjuvant chemotherapy in colorectal cancer patients with peritoneal metastases: 'the estimated volume index' (EVI) - Charlotte Rijsemus, Amsterdam / NL
08:00
6
The definition of a near-complete response after neoadjuvant (chemo)radiotherapy for rectal cancer: results of an expert survey - Petra Custers, Amsterdam / NL
08:00
7
Prognostic models for classifying rectal tumour response to therapy using radiomics and CNN features - Gisella Guido, Roma / IT
08:00
8
Added value of multiparametric PET/MRI in staging of rectal cancer - Alexander Herold, Vienna / AT
08:00
9
Diffusion weighted MRI (DWI) and carbon ion radiotherapy (CIRT): a preliminary study on DWI predictive role in CIRT re-treatment of locally recurrent rectal cancer - Dario Nicola Boccuzzi, Como / IT
08:00
10
Role of MRI for early tumour response evaluation in anal cancer after five weeks of chemoradiotherapy in guiding boost strategies - Doenja Lambregts, Amsterdam / NL
08:00
